In Alzheimer’s disease, Aβ and tau can activate inflammasomes, leading to neuroinflammation and the release of neurotoxic factors, ultimately causing neuronal damage (5). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.